RUGGERI, ENRICA
 Distribuzione geografica
Continente #
NA - Nord America 422
EU - Europa 116
AS - Asia 62
AF - Africa 1
Totale 601
Nazione #
US - Stati Uniti d'America 420
IT - Italia 30
SE - Svezia 29
CN - Cina 23
SG - Singapore 19
DE - Germania 16
RU - Federazione Russa 14
VN - Vietnam 12
GB - Regno Unito 11
FI - Finlandia 6
FR - Francia 5
IN - India 3
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AT - Austria 1
BD - Bangladesh 1
CA - Canada 1
DK - Danimarca 1
EG - Egitto 1
LT - Lituania 1
LV - Lettonia 1
NL - Olanda 1
PA - Panama 1
PK - Pakistan 1
TR - Turchia 1
Totale 601
Città #
Fairfield 79
Chandler 60
Woodbridge 40
Ashburn 33
Seattle 32
Cambridge 25
Houston 23
Nyköping 20
Ann Arbor 18
Singapore 16
Wilmington 15
Munich 8
Ostuni 8
Lawrence 7
Dong Ket 6
New York 6
Roxbury 6
Brooklyn 5
Helsinki 5
Los Angeles 5
Bari 4
Beijing 4
Des Moines 4
Kunming 4
Trani 4
Dearborn 3
Edinburgh 3
Hanoi 3
Inglewood 3
Nanjing 3
San Diego 3
Grottaglie 2
Guangzhou 2
Hounslow 2
Norwalk 2
Pisa 2
Pune 2
Redwood City 2
Strasbourg 2
Washington 2
Cairo 1
Chengdu 1
Copenhagen 1
Dhaka 1
Hebei 1
Hefei 1
Istanbul 1
Jiaxing 1
Jinan 1
London 1
Nanchang 1
Panama City 1
Paris 1
Princeton 1
Quanzhou 1
Riga 1
Rome 1
San Mateo 1
Shenyang 1
Taranto 1
Toronto 1
Vienna 1
Xian 1
Yerevan 1
Totale 497
Nome #
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 122
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 109
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 103
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 99
ADIPOQ rs266729 G/C gene polymorphism and plasmatic adipocytokines connect metabolic syndrome to colorectal cancer 88
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 70
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial 49
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 14
Totale 654
Categoria #
all - tutte 3.066
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.066


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020111 0 0 0 0 0 15 27 25 18 11 8 7
2020/2021154 2 17 2 37 11 22 8 14 1 23 4 13
2021/202264 2 0 0 0 5 9 2 5 9 3 9 20
2022/2023129 13 21 14 12 10 13 7 17 15 1 4 2
2023/202438 1 5 6 0 9 12 0 0 0 2 0 3
2024/202561 7 3 20 10 5 16 0 0 0 0 0 0
Totale 654